Financials Biomerica, Inc.

Equities

BMRA

US09061H3075

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:10:24 2024-04-29 pm EDT 5-day change 1st Jan Change
0.592 USD -11.01% Intraday chart for Biomerica, Inc. -18.09% -52.51%

Valuation

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Capitalization 1 35.21 21.75 73.14 44.9 44.98 23.05
Enterprise Value (EV) 1 34.01 21.06 66.29 42.32 40.44 14.41
P/E ratio -23.8 x -8.65 x -28.1 x -6.73 x -9.72 x -2.72 x
Yield - - - - - -
Capitalization / Revenue 6.33 x 4.18 x 10.9 x 6.24 x 2.38 x 4.32 x
EV / Revenue 6.11 x 4.05 x 9.9 x 5.88 x 2.14 x 2.7 x
EV / EBITDA -26.3 x -9.36 x -29.2 x -6.63 x -9.64 x -2.1 x
EV / FCF -43.7 x -13.8 x -19.9 x -15 x 37.8 x -5.84 x
FCF Yield -2.29% -7.25% -5.04% -6.66% 2.64% -17.1%
Price to Book 8.36 x 5.47 x 5.35 x 4.87 x 5.41 x 1.97 x
Nbr of stocks (in thousands) 8,652 9,667 11,305 12,302 12,852 16,822
Reference price 2 4.070 2.250 6.470 3.650 3.500 1.370
Announcement Date 8/29/18 8/29/19 8/31/20 8/27/21 8/29/22 8/25/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net sales 1 5.564 5.201 6.693 7.199 18.87 5.339
EBITDA 1 -1.295 -2.25 -2.274 -6.384 -4.195 -6.849
EBIT 1 -1.482 -2.413 -2.403 -6.522 -4.534 -6.933
Operating Margin -26.63% -46.39% -35.9% -90.6% -24.03% -129.86%
Earnings before Tax (EBT) 1 -1.434 -2.369 -2.332 -6.456 -4.507 -7.089
Net income 1 -1.466 -2.393 -2.339 -6.469 -4.531 -7.14
Net margin -26.34% -46.01% -34.95% -89.86% -24.01% -133.73%
EPS 2 -0.1710 -0.2600 -0.2301 -0.5423 -0.3600 -0.5044
Free Cash Flow 1 -0.7777 -1.526 -3.338 -2.818 1.07 -2.465
FCF margin -13.98% -29.35% -49.88% -39.14% 5.67% -46.17%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/29/18 8/29/19 8/31/20 8/27/21 8/29/22 8/25/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: May 2022 Q2
Net sales 1 4.647
EBITDA -
EBIT 1 -1.13
Operating Margin -24.31%
Earnings before Tax (EBT) -
Net income 1 -1.125
Net margin -24.22%
EPS 2 -0.0900
Dividend per Share -
Announcement Date 1/12/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.2 0.69 6.86 2.58 4.54 8.64
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.78 -1.53 -3.34 -2.82 1.07 -2.47
ROE (net income / shareholders' equity) -33.3% -57.6% -25.7% -55.2% -51.6% -71.2%
ROA (Net income/ Total Assets) -18.1% -28.8% -13.3% -28% -24.4% -33.6%
Assets 1 8.104 8.306 17.53 23.07 18.54 21.28
Book Value Per Share 2 0.4900 0.4100 1.210 0.7500 0.6500 0.7000
Cash Flow per Share 2 0.1400 0.0700 0.7400 0.3400 0.4600 0.5800
Capex 1 0.13 0.1 0.03 0.14 0.06 0.06
Capex / Sales 2.34% 1.94% 0.5% 1.89% 0.3% 1.2%
Announcement Date 8/29/18 8/29/19 8/31/20 8/27/21 8/29/22 8/25/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMRA Stock
  4. Financials Biomerica, Inc.